CUAMC
ITCI

China Universal Asset Management Company’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

China Universal Asset Management Company’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,328
Closed -$2.81M – 501
2025
Q1 		$2.81M Sell
21,328
-1,152
-5% -$144K 0.26% 82
2024
Q4 		$1.88M Buy
22,480
+2,157
+11% +$177K 0.18% 109
2024
Q3 		$1.49M Buy
20,323
+7,920
+64% +$595K 0.16% 110
2024
Q2 		$849K Sell
12,403
-6,210
-33% -$431K 0.12% 111
2024
Q1 		$1.29M Buy
18,613
+7,480
+67% +$514K 0.16% 109
2023
Q4 		$797K Buy
11,133
+8,668
+352% +$499K 0.16% 124
2023
Q3 		$128K Buy
2,465
+1,207
+96% +$70.3K 0.04% 178
2023
Q2 		$79.7K Sell
1,258
-25
-2% -$1.56K 0.02% 162
2023
Q1 		$69.5K Buy
1,283
+321
+33% +$15.5K 0.02% 141
2022
Q4 		$50.9K Buy
962
+78
+9% +$3.91K 0.02% 137
2022
Q3 		$41K Buy
+884
New +$46.2K 0.02% 129

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

China Universal Asset Management Company's ITCI Position: Q2 2025 in Review

China Universal Asset Management Company sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 21,328 shares — an estimated $2.81M sold.

China Universal Asset Management Company first reported a position in ITCI in Q3 2022 and held it in 11 quarters. The position peaked at $2.81M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • China Universal Asset Management Company reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 21,328 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $2.81M.
  • China Universal Asset Management Company first reported a position in Intra-Cellular Therapies Inc. in Q3 2022 and held it in 11 quarters.
  • China Universal Asset Management Company's Intra-Cellular Therapies Inc. position peaked at $2.81M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on China Universal Asset Management Company's 13F filing for Q2 2025, filed 28 Aug 2025.